Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1-specific CD8+ T cells identified by peptide-MHC-class-I tetramers

Cellular Immunology

Volumn 231, Issue 1-2, 2004, Pages 112-125

  Bohnenkamp, Hermann R ^a,b   Coleman, Julia ^b   Burchell, Joy M ^b   Taylor Papadimitriou, Joyce ^b   Noll, Thomas ^a  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Cross priming; Dendritic cells; MUC1

Indexed keywords

CELL PROTEIN; CYTOKINE; EPITOPE; GAMMA INTERFERON; HLA A ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MELAN A; MUCIN; MUCIN 1; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BREAST CARCINOMA; CANCER IMMUNOTHERAPY; CELL LYSATE; CELL STRAIN MCF 7; COMPARATIVE STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; MONOCYTE; POLARIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADJUVANTS, IMMUNOLOGIC; BREAST NEOPLASMS; CA-15-3 ANTIGEN; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL EXTRACTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYTOKINES; DENDRITIC CELLS; DINOPROSTONE; ENDOCYTOSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; RECEPTORS, CHEMOKINE; T-LYMPHOCYTES, HELPER-INDUCER;

MINK CELL FOCUS-FORMING VIRUS;

EID: 20144379031     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellimm.2004.12.007     Document Type: Article

References (62)

1. R.M. Steinman, D. Hawiger, and M.C. Nussenzweig Tolerogenic dendritic cells Annu. Rev. Immunol. 21 2003 685 711
2. S.M. Barratt-Boyes, and C.G. Figdor Current issues in delivering DCs for immunotherapy Cytotherapy 6 2004 105 110
3. M.V. Dhodapkar, R.M. Steinman, J. Krasovsky, C. Munz, and N. Bhardwaj Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells J. Exp. Med. 193 2001 233 238
4. M. Gunzer, and S. Grabbe Dendritic cells in cancer immunotherapy Crit. Rev. Immunol. 21 2001 133 145
5. S. Gendler, J. Taylor-Papadimitriou, T. Duhig, J. Rothbard, and J. Burchell A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats J. Biol. Chem. 263 1988 12820 12823
6. S.J. Gendler, C.A. Lancaster, J. Taylor-Papadimitriou, T. Duhig, N. Peat, J. Burchell, L. Pemberton, E.N. Lalani, and D. Wilson Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin J. Biol. Chem. 265 1990 15286 15293
7. C.A. Lancaster, N. Peat, T. Duhig, D. Wilson, J. Taylor-Papadimitriou, and S.J. Gendler Structure and expression of the human polymorphic epithelial mucin gene: an expressed VNTR unit Biochem. Biophys. Res. Commun. 173 1990 1019 1029
8. M. Shimizu, and K. Yamauchi Isolation and characterization of mucin-like glycoprotein in human milk fat globule membrane J. Biochem. (Tokyo) 91 1982 515 524
9. S. Zotter, P.C. Hageman, A. Lossnitzer, J. van den Tweel, J. Hilkens, W.J. Mooi, and J. Hilgers Monoclonal antibodies to epithelial sialomucins recognize epitopes at different cellular sites in adenolymphomas of the parotid gland Int. J. Cancer 3 Suppl. 1988 38 44
10. I. Correa, T. Plunkett, A. Vlad, A. Mungul, J. Candelora-Kettel, J.M. Burchell, J. Taylor-Papadimitriou, and O.J. Finn Form and pattern of MUC1 expression on T cells activated in vivo or in vitro suggests a function in T-cell migration Immunology 108 2003 32 41
11. J.F. Chang, H.L. Zhao, J. Phillips, and G. Greenburg The epithelial mucin, MUC1, is expressed on resting T lymphocytes and can function as a negative regulator of T cell activation Cell Immunol. 201 2000 83 88
12. S. Cloosen, M. Thio, A. Vanclee, E.B. van Leeuwen, B.L. Senden-Gijsbers, E.B. Oving, W.T. Germeraad, and G.M. Bos Mucin-1 is expressed on dendritic cells, both in vitro and in vivo Int. Immunol. 16 2004 1561 1571
13. A. Girling, J. Bartkova, J. Burchell, S. Gendler, C. Gillett, and J. Taylor-Papadimitriou A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas Int. J. Cancer 43 1989 1072 1076
14. C. Langner, M. Ratschek, P. Rehak, L. Schips, and R. Zigeuner Expression of MUC1 (EMA) and E-cadherin in renal cell carcinoma: a systematic immunohistochemical analysis of 188 cases Mod. Pathol. 17 2004 180 188
15. H. Noto, T. Takahashi, Y. Makiguchi, T. Hayashi, Y. Hinoda, and K. Imai Cytotoxic T lymphocytes derived from bone marrow mononuclear cells of multiple myeloma patients recognize an underglycosylated form of MUC1 mucin Int. Immunol. 9 1997 791 798
16. S. Zhang, H.S. Zhang, V.E. Reuter, S.F. Slovin, H.I. Scher, and P.O. Livingston Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers Clin. Cancer Res. 4 1998 295 302
17. J. Taylor-Papadimitriou, J.M. Burchell, T. Plunkett, R. Graham, I. Correa, D. Miles, and M. Smith MUC1 and the immunobiology of cancer J. Mammary Gland Biol. Neoplasia 7 2002 209 221
18. P. Brossart, K.S. Heinrich, G. Stuhler, L. Behnke, V.L. Reichardt, S. Stevanovic, A. Muhm, H.G. Rammensee, L. Kanz, and W. Brugger Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies Blood 93 1999 4309 4317
19. L.C. Heukamp, S.H. van der Burg, J.W. Drijfhout, C.J. Melief, J. Taylor-Papadimitriou, and R. Offringa Identification of three non-VNTR MUC1-derived HLA-A*0201-restricted T-cell epitopes that induce protective anti-tumor immunity in HLA-A2/K(b)-transgenic mice Int. J. Cancer 91 2001 385 392
20. M.R. Muller, F. Grunebach, A. Nencioni, and P. Brossart Transfection of dendritic cells with RNA induces CD4- and CD8-mediated T cell immunity against breast carcinomas and reveals the immunodominance of presented T cell epitopes J. Immunol. 170 2003 5892 5896
21. P. Brossart, and M.J. Bevan Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines Blood 90 1997 1594 1599
22. P. Guermonprez, J. Valladeau, L. Zitvogel, C. Thery, and S. Amigorena Antigen presentation and T cell stimulation by dendritic cells Annu. Rev. Immunol. 20 2002 621 667
23. S.L. Constant, and K. Bottomly Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches Annu. Rev. Immunol. 15 1997 297 322
24. M.L. Kapsenberg Dendritic-cell control of pathogen-driven T-cell polarization Nat. Rev. Immunol. 3 2003 984 993
25. A. O'Garra, and N. Arai The molecular basis of T helper 1 and T helper 2 cell differentiation Trends Cell Biol. 10 2000 542 550
26. A. Langenkamp, M. Messi, A. Lanzavecchia, and F. Sallusto Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells Nat. Immunol. 1 2000 311 316
27. H.D. Soule, J. Vazguez, A. Long, S. Albert, and M. Brennan A human cell line from a pleural effusion derived from a breast carcinoma J. Natl. Cancer Inst. 51 1973 1409 1416
28. R. Cailleau, R. Young, M. Olive, and W.J. Reeves Jr. Breast tumor cell lines from pleural effusions J. Natl. Cancer Inst. 53 1974 661 674
29. K.J. Wiechelman, R.D. Braun, and J.D. Fitzpatrick Investigation of the bicinchoninic acid protein assay: identification of the groups responsible for color formation Anal. Biochem. 175 1988 231 237
30. H.R. Bohnenkamp, and T. Noll Process development for standardized generation of mature monocyte-derived dendritic cells suitable for clinical application Cytotechnology 42 2003 121 131
31. J. Burchell, H. Durbin, and J. Taylor-Papadimitriou Complexity of expression of antigenic determinants, recognized by monoclonal antibodies HMFG-1 and HMFG-2, in normal and malignant human mammary epithelial cells J. Immunol. 131 1983 508 513
32. J. Burchell, S. Gendler, J. Taylor-Papadimitriou, A. Girling, A. Lewis, R. Millis, and D. Lamport Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin Cancer Res. 47 1987 5476 5482
33. K. Duperrier, A. Eljaafari, C. Dezutter-Dambuyant, C. Bardin, C. Jacquet, K. Yoneda, D. Schmitt, L. Gebuhrer, and D. Rigal Distinct subsets of dendritic cells resembling dermal DCs can be generated in vitro from monocytes, in the presence of different serum supplements J. Immunol. Methods 238 2000 119 131
34. T. Vasselon, E. Hailman, R. Thieringer, and P.A. Detmers Internalization of monomeric lipopolysaccharide occurs after transfer out of cell surface CD14 J. Exp. Med. 190 1999 509 521
35. T. Luft, M. Jefford, P. Luetjens, T. Toy, H. Hochrein, K.A. Masterman, C. Maliszewski, K. Shortman, J. Cebon, and E. Maraskovsky Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets Blood 100 2002 1362 1372
36. D. Valmori, J.F. Fonteneau, C.M. Lizana, N. Gervois, D. Lienard, D. Rimoldi, V. Jongeneel, F. Jotereau, J.C. Cerottini, and P. Romero Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues J. Immunol. 160 1998 1750 1758
37. P. Romero, N. Gervois, J. Schneider, P. Escobar, D. Valmori, C. Pannetier, A. Steinle, T. Wolfel, D. Lienard, V. Brichard, A. van Pel, F. Jotereau, and J.C. Cerottini Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted Melan-A/MART-1 antigenic peptide in melanoma J. Immunol. 159 1997 2366 2374
38. Y. Kawakami, S. Eliyahu, K. Sakaguchi, P.F. Robbins, L. Rivoltini, J.R. Yannelli, E. Appella, and S.A. Rosenberg Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes J. Exp. Med. 180 1994 347 352
39. R.R. Pogue, J. Eron, J.A. Frelinger, and M. Matsui Amino-terminal alteration of the HLA-A*0201-restricted human immunodeficiency virus pol peptide increases complex stability and in vitro immunogenicity Proc. Natl. Acad. Sci. USA 92 1995 8166 8170
40. F. Gotch, J. Rothbard, K. Howland, A. Townsend, and A. McMichael Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2 Nature 326 1987 881 882
41. J. Alexander, J. Sidney, S. Southwood, J. Ruppert, C. Oseroff, A. Maewal, K. Snoke, H.M. Serra, R.T. Kubo, and A. Sette Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides Immunity 1 1994 751 761
42. H.R. Bohnenkamp, U. Hilbert, and T. Noll Bioprocess development for the cultivation of human T-lymphocytes in a clinical scale Cytotechnology 38 2002 135 145
43. R. Manz, M. Assenmacher, E. Pfluger, S. Miltenyi, and A. Radbruch Analysis and sorting of live cells according to secreted molecules, relocated to a cell-surface affinity matrix Proc. Natl. Acad. Sci. USA 92 1995 1921 1925
44. A. Blockzjil, K. Nilsson, and O. Nilsson Epitope characterization of MUC1 antibodies Tumour Biol. 19 Suppl. 1 1998 46 56
45. D. Walsh, S.M. Luckie, M.C. Cummings, T.M. Antalis, and A. McGuckin Heterogeneity of MUC1 expression by human breast carcinoma cell lines in vivo and in vitro Breast Cancer Res. Treat. 58 2000 255 266
46. P.G. Coulie, and P. van der Bruggen T-cell responses of vaccinated cancer patients Curr. Opin. Immunol. 15 2003 131 137
47. A. Zippelius, M.J. Pittet, P. Batard, N. Rufer, M. de Smedt, P. Guillaume, K. Ellefsen, D. Valmori, D. Lienard, J. Plum, H.R. MacDonald, D.E. Speiser, J.C. Cerottini, and P. Romero Thymic selection generates a large T cell pool recognizing a self-peptide in humans J. Exp. Med. 195 2002 485 494
48. C. Reis e Sousa, and R.N. Germain Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a of cells engaged in phagocytosis J. Exp. Med. 182 1995 841 851
49. Z. Shen, G. Reznikoff, G. Dranoff, and K.L. Rock Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules J. Immunol. 158 1997 2723 2730
50. Y. Kotera, K. Shimizu, and J.J. Mule Comparative analysis of necrotic and apoptotic tumor cells as a source of antigen(s) in dendritic cell-based immunization Cancer Res. 61 2001 8105 8109
51. L.A. Lambert, G.R. Gibson, M. Maloney, and R.J. Barth Jr. Equipotent generation of protective antitumor immunity by various methods of dendritic cell loading with whole cell tumor antigens J. Immunother. 24 2001 232 236
52. T. Bachleitner-Hofmann, A. Stift, J. Friedl, R. Pfragner, K. Radelbauer, P. Dubsky, G. Schuller, T. Benko, B. Niederle, C. Brostjan, R. Jakesz, and M. Gnant Stimulation of autologous antitumor T-cell responses against medullary thyroid carcinoma using tumor lysate-pulsed dendritic cells J. Clin. Endocrinol. Metab. 87 2002 1098 1104
53. W. Herr, E. Ranieri, W. Olson, H. Zarour, L. Gesualdo, and W.J. Storkus Mature dendritic cells pulsed with freeze-thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4(+) and CD8(+) T lymphocyte responses Blood 96 2000 1857 1864
54. M. Schnurr, P. Galambos, C. Scholz, F. Then, M. Dauer, S. Endres, and A. Eigler Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines Cancer Res. 61 2001 6445 6450
55. P. Thumann, I. Moc, J. Humrich, T.G. Berger, E.S. Schultz, G. Schuler, and L. Jenne Antigen loading of dendritic cells with whole tumor cell preparations J. Immunol. Methods 277 2003 1 16
56. R. Kass, S. Bellone, M. Palmieri, S. Cane, E. Bignotti, R. Henry-Tillman, L. Hutchins, M.J. Cannon, S. Klimberg, and A.D. Santin Restoration of tumor-specific HLA class I restricted cytotoxicity in tumor infiltrating lymphocytes of advanced breast cancer patients by in vitro stimulation with tumor antigen-pulsed autologous dendritic cells Breast Cancer Res. Treat. 80 2003 275 285
57. Y.J. Wen, R. Min, G. Tricot, B. Barlogie, and Q. Yi Tumor lysate-specific cytotoxic T lymphocytes in multiple myeloma: promising effector cells for immunotherapy Blood 99 2002 3280 3285
58. Z. Vegh, and A. Mazumder Generation of tumor cell lysate-loaded dendritic cells preprogrammed for IL-12 production and augmented T cell response Cancer Immunol. Immunother. 52 2003 67 79
59. F. Sallusto, and A. Lanzavecchia The instructive role of dendritic cells on T-cell responses Arthritis Res. 4 Suppl. 3 2002 S127 S132
60. M. Feuerer, P. Beckhove, L. Bai, E.F. Solomayer, G. Bastert, I.J. Diel, C. Pedain, M. Oberniedermayr, V. Schirrmacher, and V. Umansky Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow Nat. Med. 7 2001 452 458
61. M.C. Wolkers, N. Brouwenstijn, A.H. Bakker, M. Toebes, and T.N. Schumacher Antigen bias in T cell cross-priming Science 304 2004 1314 1317
62. R.M. Kedl, J.W. Kappler, and P. Marrack Epitope dominance, competition and T cell affinity maturation Curr. Opin. Immunol. 15 2003 120 127